Hemorrhagic stroke laboratory findings

Hemorrhagic stroke Microchapters
Main Stroke Page
Ischemic Stroke Page
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stroke from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Emergency Diagnosis and Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Other Imaging Findings
Treatment
Early Assessment
NIH Stroke Scale
Management
Surgery
Rehabilitation
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) Management of ICH
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012) Management of aSAH
AHA/ASA Guideline Recommendation for the Primary Prevention of Stroke (2014) Primary Prevention of Stroke
AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (2014) Overview Sex-Specific Risk Factors Pregnancy and Complications Cerebral Venous Thrombosis Oral Contraceptives Menopause and Postmenopausal Hormonal Therapy Risk Factors Commoner in Women Migraine with Aura Obesity, Metabolic Syndrome, and Lifestyle Factors Atrial Fibrillation Prevention
Case Studies
Case #1
Hemorrhagic stroke laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemorrhagic stroke laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemorrhagic stroke laboratory findings
CDC on Hemorrhagic stroke laboratory findings
Hemorrhagic stroke laboratory findings in the news
Blogs on Hemorrhagic stroke laboratory findings
Directions to Hospitals Treating Stroke
Risk calculators and risk factors for Hemorrhagic stroke laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Routine laboratory studies in patient with intracerebral hemorrhage should include complete blood count (CBC) with platelets, electrolytes, renal function, coagulation studies (prothrombin time (PT), partial thromboplastin time (PTT), and INR), toxicology screen, blood glucose level, and pregnancy test in women of childbearing age.

Laboratory findings

Blood test	Test result	Rationale
Complete blood count and platelet	Leukocytosis Polycythemia Thrombocytopenia	Monitor for infection Assess hematocrit and platelet count to identify hemorrhagic risk and complications
BMP/Osmolarity	Increased or decreased serum NA2+, K+, Ca2+ Change in osmolarity	Monitor osmolarity for guidance of osmotic diuresis
PT/APTT/INR	Increased PT/APTT/INR	Identify a coagulopathy
BUN/Creatinine	Increased BUN and creatinine	May be associated with poor prognosis in patients with intracerebral hemorrhage and hematoma expansion
Toxicology screen/Serum alcohol level	Increased levels of serum	Identify illicit drug use or excessive alcohol Identify exogenous toxins that can cause intracerebral hemorrhage (ICH)
HbA1C	Increased levels of HbA1c
Blood glucose levels	Increased or decreased levels of blood glucose	May be associated with poor prognosis in patients with Intracerebral hemorrhage
Cardiac enzymes	Increased serum levels of Trop I, Trop T, CK-MB	Elevated Trop T levels are associated with poor prognosis May suggest ongoing myocardial ischemia
Pregnancy test	Serum and urine B-HCG	Rule out pregnancy in all female patients with hemorrhagic stroke

References

Template:WS Template:WH